Illustration: A. Canamucio I came to this country in 1969, trying to be a pathology resident. After finishing my residency, I decided to try my hand at research. Deep down I suspect that I used it as a ruse to prolong my already long apprenticeship and delay having to make an honest living as a practicing pathologist. A particularly influential event that convinced me to enroll in the immunology program rather than any other was a journal club presentation by Frank Lilly, who was then chairman o
| Illustration: A. Canamucio |
 |
The paper that Frank presented was a somewhat theoretical argument by Niels Jerne,1,2 on a possible model for the emergence of the bewilderingly large repertoire of antigen recognition apparently inherent in the mammalian immune system.3 The argument presented by Jerne was at once so talmudically convoluted and improbably lucid that I felt compelled to work ...
When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.
View this Issue
In this half-day virtual summit, a series of presentations will explore the scientific, regulatory, and operational factors impacting the use of in vitro NAMs in drug discovery.
In this webinar, scientists will discuss innovations that are unlocking new insights into immunity.
In this webinar, Magdalena Pacewicz will highlight how to use AUC to characterize AAVs as part of ensuring regulatory compliance.
Discover how the latest cancer research models and their applications help scientists pursue breakthrough cancer therapy research.
Chief Business Officer Dr. Rob Burgess Shares How Sino Biological Is Empowering Global Biomedical Research Through Precision, Quality, and Innovation on an Exclusive Segment on Fox Business Network airing on February 1, 2026 at 4:30pm EST
Sino Biological, Inc. has announced the accelerated availability and development of critical research tools to support the global scientific community in combating NiV.
Collaboration will bring next generation orchestration and modular automation to scientists worldwide
The ranking places Refeyn among a cohort of high-growth UK technology firms spanning sectors including the life sciences, energy and sustainability, telecommunications, and digital technology.
